Cardiology

Results from the COBRA-REDUCE trial reported

For patients undergoing percutaneous coronary intervention (PCI) that also require oral anticoagulation, treatment with a nanotechnology polymer-coated stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding ...

Cardiology

Results from host-reduce-polytech-ACS trial reported

A randomized clinical trial found that drug-eluting stents (DES) with durable polymers are non-inferior to DES with biodegradable polymers in patients with acute coronary syndrome (ACS).

Cardiology

Mayo will test robotic heart procedure for rural patients

Mayo Clinic researchers are poised this spring to test a remote cardiac procedure that could be a major breakthrough for rural hospital care—a procedure in which a patient's clogged artery is propped open by robotic tools ...

Cardiology

UM to research new aneurysm stent in upcoming multicenter trial

Robert M. Starke, M.D., M.Sc., an experienced neurosurgeon and researcher with the University of Miami Health System and Miller School of Medicine, has been conducting laboratory studies on a specialized stent designed to ...

Cardiology

Results from the OAC-ALONE trial reported

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable ...

page 22 from 34